;PMID: 10681414
;source_file_979.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..36] = [t:0..36]
;1)sentence:[e:42..184] = [t:42..184]
;2)section:[e:188..338] = [t:188..338]
;3)section:[e:342..420] = [t:342..420]
;4)sentence:[e:424..582] = [t:424..582]
;5)sentence:[e:584..916] = [t:584..916]
;6)sentence:[e:917..1029] = [t:917..1029]
;7)sentence:[e:1030..1167] = [t:1030..1167]
;8)sentence:[e:1168..1251] = [t:1168..1251]
;9)sentence:[e:1252..1401] = [t:1252..1401]
;10)sentence:[e:1402..1621] = [t:1402..1621]
;11)sentence:[e:1622..1721] = [t:1622..1721]
;12)sentence:[e:1722..1895] = [t:1722..1895]
;13)sentence:[e:1896..2033] = [t:1896..2033]
;14)sentence:[e:2034..2299] = [t:2034..2299]
;15)section:[e:2303..2348] = [t:2303..2348]

;section 0 Span:0..36
;J Lipid Res. 2000 Feb;41(2):298-304.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..7] Lipid) (NNP:[8..11] Res) (.:[11..12] .)
        (CD:[13..17] 2000) (CC:[18..25] Feb;41-LRB-) (CD:[25..26] 2)
        (-RRB-:[26..27] -RRB-) (CD:[27..31] :298) (HYPH:[31..32] -)
        (CD:[32..35] 304) (.:[35..36] .)))

;sentence 1 Span:42..184
;Ileal bile acid transport regulates bile acid pool, synthesis, and plasma 
;cholesterol levels differently in cholesterol-fed rats and rabbits.
;[48..57]:substance:"bile acid"
;[78..87]:substance:"bile acid"
;[117..128]:substance:"cholesterol"
;[151..162]:substance:"cholesterol"
(SENT
  (S-HLN
    (NP-SBJ (JJ:[42..47] Ileal)
      (NML (NN:[48..52] bile) (NN:[53..57] acid))
      (NN:[58..67] transport))
    (VP (VBZ:[68..77] regulates)
      (NP
        (NP
          (NML
            (NML-2 (NN:[78..82] bile) (NN:[83..87] acid))
            (NN:[88..92] pool))
          (NML-3 (-NONE-:[92..92] *P*)))
        (,:[92..93] ,)
        (NP
          (NML-2 (-NONE-:[93..93] *P*))
          (NN:[94..103] synthesis)
          (NML-3 (-NONE-:[103..103] *P*)))
        (,:[103..104] ,) (CC:[105..108] and)
        (NP (NN:[109..115] plasma) (NN:[117..128] cholesterol)
          (NML-3 (NNS:[129..135] levels))))
      (ADVP (RB:[136..147] differently))
      (PP-LOC (IN:[148..150] in)
        (NP
          (NP
            (ADJP-1 (NN:[151..162] cholesterol) (HYPH:[162..163] -)
                    (VBN:[163..166] fed))
            (NNS:[167..171] rats))
          (CC:[172..175] and)
          (NP
            (ADJP-1 (-NONE-:[175..175] *P*))
            (NNS:[176..183] rabbits)))))
    (.:[183..184] .)))

;section 2 Span:188..338
;Xu G, Shneider BL, Shefer S, Nguyen LB, Batta AK, Tint GS, Arrese M, 
;Thevananther S, Ma L, Stengelin S, Kramer W, Greenblatt D, Pcolinsky M, Salen
;G.
(SEC
  (FRAG (NNP:[188..190] Xu) (NNP:[191..192] G) (,:[192..193] ,)
        (NNP:[194..202] Shneider) (NNP:[203..205] BL) (,:[205..206] ,)
        (NNP:[207..213] Shefer) (NNP:[214..216] S,) (NNP:[217..223] Nguyen)
        (NNP:[224..226] LB) (,:[226..227] ,) (NNP:[228..233] Batta)
        (NNP:[234..236] AK) (,:[236..237] ,) (NNP:[238..242] Tint)
        (NNP:[243..245] GS) (,:[245..246] ,) (NNP:[247..253] Arrese)
        (NNP:[254..256] M,) (NNP:[258..270] Thevananther) (NNP:[271..273] S,)
        (NNP:[274..276] Ma) (NNP:[277..279] L,) (NNP:[280..289] Stengelin)
        (NNP:[290..292] S,) (NNP:[293..299] Kramer) (NNP:[300..301] W)
        (,:[301..302] ,) (NNP:[303..313] Greenblatt) (NNP:[314..315] D)
        (,:[315..316] ,) (NNP:[317..326] Pcolinsky) (NNP:[327..329] M,)
        (NNP:[330..335] Salen) (NNP:[336..338] G.)))

;section 3 Span:342..420
;Medical Services, Veterans Affairs Medical Center, East Orange, NJ 07018,
;USA.
(SEC
  (FRAG (NNP:[342..349] Medical) (NNPS:[350..358] Services) (,:[358..359] ,)
        (NNP:[360..368] Veterans) (NNP:[369..376] Affairs)
        (NNP:[377..384] Medical) (NNP:[385..391] Center) (,:[391..392] ,)
        (NNP:[393..397] East) (NNP:[398..404] Orange) (,:[404..405] ,)
        (NNP:[406..408] NJ) (CD:[409..414] 07018) (,:[414..415] ,)
        (NNP:[416..419] USA) (.:[419..420] .)))

;sentence 4 Span:424..582
;We investigated the effect of ileal bile acid transport on the regulation of 
;classic and alternative bile acid synthesis in cholesterol-fed rats and
;rabbits.
;[460..469]:substance:"bile acid"
;[526..535]:substance:"bile acid"
;[549..560]:substance:"cholesterol"
(SENT
  (S
    (NP-SBJ (PRP:[424..426] We))
    (VP (VBD:[427..439] investigated)
      (NP
        (NP (DT:[440..443] the) (NN:[444..450] effect))
        (PP (IN:[451..453] of)
          (NP (JJ:[454..459] ileal)
            (NML (NN:[460..464] bile) (NN:[465..469] acid))
            (NN:[470..479] transport))))
      (PP (IN:[480..482] on)
        (NP
          (NP (DT:[483..486] the) (NN:[487..497] regulation))
          (PP (IN:[498..500] of)
            (NP
              (NP (JJ:[502..509] classic)
                (NML-2 (-NONE-:[509..509] *P*)))
              (CC:[510..513] and)
              (NP (JJ:[514..525] alternative)
                (NML-2
                  (NML (NN:[526..530] bile) (NN:[531..535] acid))
                  (NN:[536..545] synthesis)))))))
      (PP (IN:[546..548] in)
        (NP
          (NP
            (ADJP-1 (NN:[549..560] cholesterol) (HYPH:[560..561] -)
                    (VBN:[561..564] fed))
            (NNS:[565..569] rats))
          (CC:[570..573] and)
          (NP
            (ADJP-1 (-NONE-:[573..573] *P*))
            (NNS:[574..581] rabbits)))))
    (.:[581..582] .)))

;sentence 5 Span:584..916
;Bile acid pool sizes, fecal bile acid outputs (synthesis rates), and the 
;activities of cholesterol 7alpha-hydroxylase (classic bile acid synthesis)
;and  cholesterol 27-hydroxylase (alternative bile acid synthesis) were
;related to  ileal bile acid transporter expression (ileal apical
;sodium-dependent bile acid  transporter, ASBT).
;[584..593]:substance:"Bile acid"
;[612..621]:substance:"bile acid"
;[672..702]:cyp450:"cholesterol 7alpha-hydroxylase"
;[712..721]:substance:"bile acid"
;[738..764]:cyp450:"cholesterol 27-hydroxylase"
;[778..787]:substance:"bile acid"
;[822..831]:substance:"bile acid"
;[832..843]:substance:"transporter"
;[862..908]:substance:"apical sodium-dependent bile acid  transporter"
;[910..914]:substance:"ASBT"
(SENT
  (S
    (NP-SBJ-2
      (NP
        (NML
          (NML (NN:[584..588] Bile) (NN:[589..593] acid))
          (NN:[594..598] pool))
        (NNS:[599..604] sizes))
      (,:[604..605] ,)
      (NP (JJ:[606..611] fecal)
        (NML (NN:[612..616] bile) (NN:[617..621] acid))
        (NNS:[622..629] outputs)
        (PRN (-LRB-:[630..631] -LRB-) (NN:[631..640] synthesis)
             (NNS:[641..646] rates) (-RRB-:[646..647] -RRB-)))
      (,:[647..648] ,) (CC:[649..652] and)
      (NP
        (NP (DT:[653..656] the) (NNS:[658..668] activities))
        (PP (IN:[669..671] of)
          (NP
            (NP
              (NP (NN:[672..683] cholesterol) (NN:[684..702] 7alpha-hydroxylase))
              (NP (-LRB-:[703..704] -LRB-) (JJ:[704..711] classic)
                (NML (NN:[712..716] bile) (NN:[717..721] acid))
                (NN:[722..731] synthesis) (-RRB-:[731..732] -RRB-)))
            (CC:[733..736] and)
            (NP
              (NP (NN:[738..749] cholesterol) (NN:[750..764] 27-hydroxylase))
              (NP (-LRB-:[765..766] -LRB-) (JJ:[766..777] alternative)
                (NML (NN:[778..782] bile) (NN:[783..787] acid))
                (NN:[788..797] synthesis) (-RRB-:[797..798] -RRB-)))))))
    (VP (VBD:[799..803] were)
      (VP (VBN:[804..811] related)
        (NP-2 (-NONE-:[811..811] *))
        (PP-CLR (TO:[812..814] to)
          (NP (JJ:[816..821] ileal)
            (NML
              (NML (NN:[822..826] bile) (NN:[827..831] acid))
              (NN:[832..843] transporter))
            (NN:[844..854] expression)
            (PRN (-LRB-:[855..856] -LRB-)
              (NP
                (NP (JJ:[856..861] ileal)
                   (JJ:[862..868] apical)
                  (ADJP (NN:[869..875] sodium) (HYPH:[875..876] -)
                        (JJ:[876..885] dependent))
                  (NML (NN:[886..890] bile) (NN:[891..895] acid))
                  (NN:[897..908] transporter))
                (,:[908..909] ,)
                (NP (NN:[910..914] ASBT)))
              (-RRB-:[914..915] -RRB-))))))
    (.:[915..916] .)))

;sentence 6 Span:917..1029
;Plasma cholesterol levels rose 2.1-times in rats (98 +/- 19  mg/dl) and
;31-times (986 +/- 188 mg/dl) in rabbits.
;[924..935]:substance:"cholesterol"
;[948..957]:quantitative-value:"2.1-times"
;[967..976]:quantitative-value:"98 +/- 19"
;[978..983]:quantitative-units:"mg/dl"
;[989..997]:quantitative-value:"31-times"
;[999..1010]:quantitative-value:"986 +/- 188"
;[1011..1016]:quantitative-units:"mg/dl"
(SENT
  (S
    (NP-SBJ (NN:[917..923] Plasma) (NN:[924..935] cholesterol)
            (NNS:[936..942] levels))
    (VP
      (VP (VBD:[943..947] rose)
        (NP-EXT=1
          (QP (CD:[948..951] 2.1) (HYPH:[951..952] -) (NNS:[952..957] times)))
        (PP-LOC=2 (IN:[958..960] in)
          (NP (NNS:[961..965] rats)))
        (PRN=3 (-LRB-:[966..967] -LRB-)
          (NP
            (NP
              (QP (CD:[967..969] 98) (SYM:[970..973] +/-) (CD:[974..976] 19))
              (NN:[978..980] mg))
            (PP (SYM:[980..981] /)
              (NP (NN:[981..983] dl))))
          (-RRB-:[983..984] -RRB-)))
      (CC:[985..988] and)
      (VP
        (NP-EXT=1
          (QP (CD:[989..991] 31) (HYPH:[991..992] -) (NNS:[992..997] times))
          (PRN (-LRB-:[998..999] -LRB-)
            (NP
              (NP
                (QP (CD:[999..1002] 986) (SYM:[1003..1006] +/-)
                    (CD:[1007..1010] 188))
                (NN:[1011..1013] mg))
              (PP (SYM:[1013..1014] /)
                (NP (NN:[1014..1016] dl))))
            (-RRB-:[1016..1017] -RRB-)))
        (PP-LOC=2 (IN:[1018..1020] in)
          (NP (NNS:[1021..1028] rabbits)))
        (PRN=3 (-NONE-:[1028..1028] *NOT*))))
    (.:[1028..1029] .)))

;sentence 7 Span:1030..1167
;The bile acid pool size  remained constant (55 +/- 17 mg vs. 61 +/- 18 mg) in
;rats but doubled (254 +/-  46 to 533 +/- 53 mg) in rabbits.
;[1034..1043]:substance:"bile acid"
;[1074..1083]:quantitative-value:"55 +/- 17"
;[1084..1086]:quantitative-units:"mg"
;[1091..1100]:quantitative-value:"61 +/- 18"
;[1101..1103]:quantitative-units:"mg"
;[1126..1151]:quantitative-value:"254 +/-  46 to 533 +/- 53"
;[1152..1154]:quantitative-units:"mg"
(SENT
  (S
    (NP-SBJ (DT:[1030..1033] The)
      (NML
        (NML (NN:[1034..1038] bile) (NN:[1039..1043] acid))
        (NN:[1044..1048] pool))
      (NN:[1049..1053] size))
    (VP
      (VP (VBD:[1055..1063] remained)
        (NP-PRD (JJ:[1064..1072] constant))
        (PRN (-LRB-:[1073..1074] -LRB-)
          (NP
            (NP
              (QP (CD:[1074..1076] 55) (SYM:[1077..1080] +/-)
                  (CD:[1081..1083] 17))
              (NN:[1084..1086] mg))
            (IN:[1087..1090] vs.)
            (NP
              (QP (CD:[1091..1093] 61) (SYM:[1094..1097] +/-)
                  (CD:[1098..1100] 18))
              (NN:[1101..1103] mg)))
          (-RRB-:[1103..1104] -RRB-))
        (PP-LOC (IN:[1105..1107] in)
          (NP (NNS:[1108..1112] rats))))
      (CC:[1113..1116] but)
      (VP (VBD:[1117..1124] doubled)
        (PRN (-LRB-:[1125..1126] -LRB-)
          (NP
            (NP
              (QP (CD:[1126..1129] 254) (SYM:[1130..1133] +/-)
                  (CD:[1135..1137] 46))
              (NML-1 (-NONE-:[1137..1137] *P*)))
            (PP (TO:[1138..1140] to)
              (NP
                (QP (CD:[1141..1144] 533) (SYM:[1145..1148] +/-)
                    (CD:[1149..1151] 53))
                (NML-1 (NN:[1152..1154] mg)))))
          (-RRB-:[1154..1155] -RRB-))
        (PP-LOC (IN:[1156..1158] in)
          (NP (NNS:[1159..1166] rabbits)))))
    (.:[1166..1167] .)))

;sentence 8 Span:1168..1251
;ASBT protein expression did not change in rats  but rose 31% (P < 0.05) in
;rabbits.
;[1168..1180]:substance:"ASBT protein"
;[1225..1228]:quantitative-value:"31%"
(SENT
  (S
    (NP-SBJ
       (NN:[1168..1172] ASBT) (NN:[1173..1180] protein)
      (NN:[1181..1191] expression))
    (VP
      (VP (VBD:[1192..1195] did) (RB:[1196..1199] not)
        (VP (VB:[1200..1206] change)
          (PP-LOC (IN:[1207..1209] in)
            (NP (NNS:[1210..1214] rats)))))
      (CC:[1216..1219] but)
      (VP (VBD:[1220..1224] rose)
        (NP-EXT (CD:[1225..1227] 31) (NN:[1227..1228] %))
        (PRN (-LRB-:[1229..1230] -LRB-)
          (S
            (NP-SBJ (NN:[1230..1231] P))
            (VP (SYM:[1232..1233] <)
              (NP (CD:[1234..1238] 0.05))))
          (-RRB-:[1238..1239] -RRB-))
        (PP-LOC (IN:[1240..1242] in)
          (NP (NNS:[1243..1250] rabbits)))))
    (.:[1250..1251] .)))

;sentence 9 Span:1252..1401
;Fecal bile acid outputs that reflected bile  acid synthesis increased 2- and
;2.4-times (P < 0.05) in cholesterol-fed rats and  rabbits, respectively.
;[1258..1267]:substance:"bile acid"
;[1291..1301]:substance:"bile  acid"
;[1322..1323]...[1333..1338]:quantitative-value:"2"..."times"
;[1329..1338]:quantitative-value:"2.4-times"
;[1353..1364]:substance:"cholesterol"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[1252..1257] Fecal)
        (NML (NN:[1258..1262] bile) (NN:[1263..1267] acid))
        (NNS:[1268..1275] outputs))
      (SBAR
        (WHNP-3 (WDT:[1276..1280] that))
        (S
          (NP-SBJ-3 (-NONE-:[1280..1280] *T*))
          (VP (VBD:[1281..1290] reflected)
            (NP
              (NML (NN:[1291..1295] bile) (NN:[1297..1301] acid))
              (NN:[1302..1311] synthesis))))))
    (VP (VBD:[1312..1321] increased)
      (NP-EXT
        (NP
          (QP (CD:[1322..1323] 2) (HYPH:[1323..1324] -)
            (NML-2 (-NONE-:[1324..1324] *P*))))
        (CC:[1325..1328] and)
        (NP
          (QP (CD:[1329..1332] 2.4) (HYPH:[1332..1333] -)
            (NML-2 (NNS:[1333..1338] times))))
        (PRN (-LRB-:[1339..1340] -LRB-)
          (S
            (NP-SBJ (NN:[1340..1341] P))
            (VP (SYM:[1342..1343] <)
              (NP (CD:[1344..1348] 0.05))))
          (-RRB-:[1348..1349] -RRB-)))
      (PP-LOC (IN:[1350..1352] in)
        (NP
          (NP
            (ADJP-1 (NN:[1353..1364] cholesterol) (HYPH:[1364..1365] -)
                    (VBN:[1365..1368] fed))
            (NNS:[1369..1373] rats))
          (CC:[1374..1377] and)
          (NP
            (ADJP-1 (-NONE-:[1377..1377] *P*))
            (NNS:[1379..1386] rabbits))))
      (,:[1386..1387] ,)
      (ADVP (RB:[1388..1400] respectively)))
    (.:[1400..1401] .)))

;sentence 10 Span:1402..1621
;Cholesterol 7alpha-hydroxylase activity rose 33% (24 +/-  2.4 vs. 18 +/- 1.6
;pmol/mg/min, P < 0.01) and mRNA levels increased 50% (P <  0.01) in rats but
;decreased 68% and 79%, respectively, in cholesterol-fed  rabbits.
;[1402..1432]:cyp450:"Cholesterol 7alpha-hydroxylase"
;[1447..1450]:quantitative-value:"33%"
;[1452..1463]:quantitative-value:"24 +/-  2.4"
;[1468..1478]:quantitative-value:"18 +/- 1.6"
;[1479..1490]:quantitative-units:"pmol/mg/min"
;[1506..1510]:substance:"mRNA"
;[1528..1531]:quantitative-value:"50%"
;[1566..1569]:quantitative-value:"68%"
;[1574..1577]:quantitative-value:"79%"
;[1596..1607]:substance:"cholesterol"
(SENT
  (S
    (NP-SBJ
       (NN:[1402..1413] Cholesterol) (NN:[1414..1432] 7alpha-hydroxylase)
      (NN:[1433..1441] activity))
    (VP (VBD:[1442..1446] rose)
      (NP-EXT
         (CD:[1447..1449] 33) (NN:[1449..1450] %)
        (PRN (-LRB-:[1451..1452] -LRB-)
          (FRAG
            (NP
              (NP
                (NP
                  (NP
                    (QP (CD:[1452..1454] 24) (SYM:[1455..1458] +/-)
                        (CD:[1460..1463] 2.4))
                    (NML-1 (-NONE-:[1463..1463] *RNR*)))
                  (PP-2 (-NONE-:[1463..1463] *RNR*))
                  (PP-3 (-NONE-:[1463..1463] *RNR*)))
                (IN:[1464..1467] vs.)
                (NP
                  (NP
                    (QP (CD:[1468..1470] 18) (SYM:[1471..1474] +/-)
                        (CD:[1475..1478] 1.6))
                    (NML-1 (-NONE-:[1478..1478] *RNR*)))
                  (PP-2 (-NONE-:[1478..1478] *RNR*))
                  (PP-3 (-NONE-:[1478..1478] *RNR*))))
              
              (NML-1 (NN:[1479..1483] pmol))
              (PP-2 (SYM:[1483..1484] /)
                (NP (NN:[1484..1486] mg)))
              (PP-3 (SYM:[1486..1487] /)
                (NP (NN:[1487..1490] min))))
            (,:[1490..1491] ,)
            (S
              (NP-SBJ (NN:[1492..1493] P))
              (VP (SYM:[1494..1495] <)
                (NP (CD:[1496..1500] 0.01)))))
          (-RRB-:[1500..1501] -RRB-))))
    (CC:[1502..1505] and)
    (S
      (NP-SBJ (NN:[1506..1510] mRNA) (NNS:[1511..1517] levels))
      (VP
        (VP (VBD:[1518..1527] increased)
          (NP-EXT
             (CD:[1528..1530] 50) (NN:[1530..1531] %)
            (PRN (-LRB-:[1532..1533] -LRB-)
              (S
                (NP-SBJ (NN:[1533..1534] P))
                (VP (SYM:[1535..1536] <)
                  (NP (CD:[1538..1542] 0.01))))
              (-RRB-:[1542..1543] -RRB-)))
          (PP-LOC (IN:[1544..1546] in)
            (NP (NNS:[1547..1551] rats))))
        (CC:[1552..1555] but)
        (VP (VBD:[1556..1565] decreased)
          (NP-EXT
            (NP (CD:[1566..1568] 68) (NN:[1568..1569] %))
            (CC:[1570..1573] and)
            (NP (CD:[1574..1576] 79) (NN:[1576..1577] %)))
          (,:[1577..1578] ,)
          (ADVP (RB:[1579..1591] respectively))
          (,:[1591..1592] ,)
          (PP-LOC (IN:[1593..1595] in)
            (NP
              (ADJP (NN:[1596..1607] cholesterol) (HYPH:[1607..1608] -)
                    (VBN:[1608..1611] fed))
              (NNS:[1613..1620] rabbits))))))
    (.:[1620..1621] .)))

;sentence 11 Span:1622..1721
;Cholesterol 27-hydroxylase activity remained unchanged in rats but rose  62%
;(P < 0.05) in rabbits.
;[1622..1648]:cyp450:"Cholesterol 27-hydroxylase"
;[1695..1698]:quantitative-value:"62%"
(SENT
  (S
    (NP-SBJ
       (NN:[1622..1633] Cholesterol) (NN:[1634..1648] 27-hydroxylase)
      (NN:[1649..1657] activity))
    (VP
      (VP (VBD:[1658..1666] remained)
        (ADJP-PRD (JJ:[1667..1676] unchanged))
        (PP-LOC (IN:[1677..1679] in)
          (NP (NNS:[1680..1684] rats))))
      (CC:[1685..1688] but)
      (VP (VBD:[1689..1693] rose)
        (NP-EXT
           (CD:[1695..1697] 62) (NN:[1697..1698] %)
          (PRN (-LRB-:[1699..1700] -LRB-)
            (S
              (NP-SBJ (NN:[1700..1701] P))
              (VP (SYM:[1702..1703] <)
                (NP (CD:[1704..1708] 0.05))))
            (-RRB-:[1708..1709] -RRB-)))
        (PP-LOC (IN:[1710..1712] in)
          (NP (NNS:[1713..1720] rabbits)))))
    (.:[1720..1721] .)))

;sentence 12 Span:1722..1895
;Classic bile acid synthesis (cholesterol  7alpha-hydroxylase) was inhibited
;in rabbits because an enlarged bile acid pool  developed from enhanced ileal
;bile acid transport.
;[1730..1739]:substance:"bile acid"
;[1751..1782]:cyp450:"cholesterol  7alpha-hydroxylase"
;[1829..1838]:substance:"bile acid"
;[1875..1884]:substance:"bile acid"
(SENT
  (S
    (NP-SBJ-1 (JJ:[1722..1729] Classic)
      (NML (NN:[1730..1734] bile) (NN:[1735..1739] acid))
      (NN:[1740..1749] synthesis)
      (PRN (-LRB-:[1750..1751] -LRB-)
         (NN:[1751..1762] cholesterol) (NN:[1764..1782] 7alpha-hydroxylase)
        (-RRB-:[1782..1783] -RRB-)))
    (VP (VBD:[1784..1787] was)
      (VP (VBN:[1788..1797] inhibited)
        (NP-1 (-NONE-:[1797..1797] *))
        (PP-LOC (IN:[1798..1800] in)
          (NP (NNS:[1801..1808] rabbits)))
        (SBAR-PRP (IN:[1809..1816] because)
          (S
            (NP-SBJ (DT:[1817..1819] an) (VBN:[1820..1828] enlarged)
              (NML (NN:[1829..1833] bile) (NN:[1834..1838] acid))
              (NN:[1839..1843] pool))
            (VP (VBD:[1845..1854] developed)
              (PP (IN:[1855..1859] from)
                (NP (VBN:[1860..1868] enhanced) (JJ:[1869..1874] ileal)
                  (NML (NN:[1875..1879] bile) (NN:[1880..1884] acid))
                  (NN:[1885..1894] transport))))))))
    (.:[1894..1895] .)))

;sentence 13 Span:1896..2033
;In contrast, in rats,  cholesterol 7alpha-hydroxylase was stimulated but the
;bile acid pool did not  enlarge because ASBT did not change.
;[1919..1949]:cyp450:"cholesterol 7alpha-hydroxylase"
;[1973..1982]:substance:"bile acid"
;[2013..2017]:substance:"ASBT"
(SENT
  (S
    (S
      (PP (IN:[1896..1898] In)
        (NP (NN:[1899..1907] contrast)))
      (,:[1907..1908] ,)
      (PP-LOC (IN:[1909..1911] in)
        (NP (NNS:[1912..1916] rats)))
      (,:[1916..1917] ,)
      (NP-SBJ-1 (NN:[1919..1930] cholesterol)
                (NN:[1931..1949] 7alpha-hydroxylase))
      (VP (VBD:[1950..1953] was)
        (VP (VBN:[1954..1964] stimulated)
          (NP-1 (-NONE-:[1964..1964] *)))))
    (CC:[1965..1968] but)
    (S
      (NP-SBJ (DT:[1969..1972] the)
        (NML (NN:[1973..1977] bile) (NN:[1978..1982] acid))
        (NN:[1983..1987] pool))
      (VP (VBD:[1988..1991] did) (RB:[1992..1995] not)
        (VP (VB:[1997..2004] enlarge)
          (SBAR-ADV (IN:[2005..2012] because)
            (S
              (NP-SBJ (NN:[2013..2017] ASBT))
              (VP (VBD:[2018..2021] did) (RB:[2022..2025] not)
                (VP (VB:[2026..2032] change))))))))
    (.:[2032..2033] .)))

;sentence 14 Span:2034..2299
;Therefore, although bile acid synthesis was  increased via different pathways
;in rats and rabbits, enhanced ileal bile acid  transport was critical for
;enlarging the bile acid pool size that exerted  feedback regulation on
;cholesterol 7alpha-hydroxylase in rabbits.
;[2054..2063]:substance:"bile acid"
;[2148..2157]:substance:"bile acid"
;[2200..2209]:substance:"bile acid"
;[2257..2287]:cyp450:"cholesterol 7alpha-hydroxylase"
(SENT
  (S
    (ADVP (RB:[2034..2043] Therefore))
    (,:[2043..2044] ,)
    (SBAR-ADV (IN:[2045..2053] although)
      (S
        (NP-SBJ-2
          (NML (NN:[2054..2058] bile) (NN:[2059..2063] acid))
          (NN:[2064..2073] synthesis))
        (VP (VBD:[2074..2077] was)
          (VP (VBN:[2079..2088] increased)
            (NP-2 (-NONE-:[2088..2088] *))
            (PP (IN:[2089..2092] via)
              (NP (JJ:[2093..2102] different) (NNS:[2103..2111] pathways)))
            (PP-LOC (IN:[2112..2114] in)
              (NP (NNS:[2115..2119] rats) (CC:[2120..2123] and)
                  (NNS:[2124..2131] rabbits)))))))
    (,:[2131..2132] ,)
    (NP-SBJ (VBN:[2133..2141] enhanced) (JJ:[2142..2147] ileal)
      (NML (NN:[2148..2152] bile) (NN:[2153..2157] acid))
      (NN:[2159..2168] transport))
    (VP (VBD:[2169..2172] was)
      (ADJP-PRD (JJ:[2173..2181] critical))
      (PP (IN:[2182..2185] for)
        (S-NOM
          (NP-SBJ (-NONE-:[2185..2185] *))
          (VP (VBG:[2186..2195] enlarging)
            (NP
              (NP (DT:[2196..2199] the)
                (NML
                  (NML (NN:[2200..2204] bile) (NN:[2205..2209] acid))
                  (NN:[2210..2214] pool))
                (NN:[2215..2219] size))
              (SBAR
                (WHNP-1 (WDT:[2220..2224] that))
                (S
                  (NP-SBJ-1 (-NONE-:[2224..2224] *T*))
                  (VP (VBD:[2225..2232] exerted)
                    (NP (NN:[2234..2242] feedback) (NN:[2243..2253] regulation))
                    (PP (IN:[2254..2256] on)
                      (NP (NN:[2257..2268] cholesterol)
                          (NN:[2269..2287] 7alpha-hydroxylase)))
                    (PP-LOC (IN:[2288..2290] in)
                      (NP (NNS:[2291..2298] rabbits)))))))))))
    (.:[2298..2299] .)))

;section 15 Span:2303..2348
;PMID: 10681414 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2303..2307] PMID) (::[2307..2308] :) (CD:[2309..2317] 10681414)
        (IN:[2318..2319] -LSB-) (NNP:[2319..2325] PubMed) (HYPH:[2326..2327] -)
        (JJ:[2328..2335] indexed) (IN:[2336..2339] for)
        (NNP:[2340..2348] MEDLINE-RSB-)))
